The administration yesterday issued an interim final rule requiring health plans to begin submitting annual information next year on prescription drug coverage and spending, including the most frequently dispensed and costliest drugs, and information on prescription drug rebates and their impact on premiums and out-of-pocket spending. The rule also requires health plans and issuers to report on total spending for health care services by type (e.g., hospital care, primary care, specialty care, prescription drugs and other medical costs, including wellness services); and premium and prescription drug spending by employers versus employees. The departments of Health and Human Services, Labor and Treasury will use the data to issue biennial reports on prescription drug pricing trends and the impact of prescription drug costs on premiums and out-of-pocket costs starting in 2023. 

Related News Articles

Headline
The Medicare Payment Advisory Commission today voted to recommend that Congress update Medicare payment rates for hospital inpatient and outpatient services by…
Headline
The Centers for Medicare & Medicaid Services yesterday released a memo and timeline outlining how it will approach implementing the Inflation…
Headline
On Dec. 15, the Department of Health and Human Services will stop collecting hospitals’ COVID-19 data through the TeleTracking portal and begin collecting the…
Headline
The AHA and seven other national hospital organizations today urged congressional leaders to waive the Statutory PAYGO sequester before yearend to prevent…
Headline
Independent, physician office and hospital outreach laboratories that meet the definition of an applicable laboratory under the Clinical Laboratory Fee…
Headline
Price increases for over 1,200 drugs exceeded inflation between July 2021 and July 2022, including many drugs used to treat cancer and other chronic conditions…